Literature DB >> 32031820

A Modular, Enantioselective Synthesis of Resolvins D3, E1, and Hybrids.

Felix Urbitsch1, Bryony L Elbert1, Josep Llaveria2, Penelope E Streatfeild1, Edward A Anderson1.   

Abstract

Resolvins D3 and E1 are important signaling molecules in the resolution of inflammation. Here, we report a convergent and flexible strategy to prepare these natural products using Hiyama-Denmark coupling of five- and six-membered cyclic alkenylsiloxanes to connect three resolvin fragments, and control the stereochemistry of the natural product (Z)-alkenes. The modular nature of this approach enables the synthesis of novel resolvin hybrids, opening up opportunities for more-extensive investigations of resolvin biology.

Entities:  

Year:  2020        PMID: 32031820      PMCID: PMC7146891          DOI: 10.1021/acs.orglett.0c00089

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


The resolution of inflammation is a complex process regulated by a host of different signaling molecules, including the resolvin, protectin, and maresin pro-resolving mediators (e.g., 1–4, Figure ).[1] These polyunsaturated fatty acids, which display nanomolar to picomolar bioactivity, stimulate a cascade of cellular resolution events involving the reduction of polymorphonuclear neutrophil infiltration and the initiation of macrophage clearance of apoptotic cells. Since numerous diseases are associated with chronic or excessive inflammation (such as cardiovascular diseases, asthma, diabetes, and neurodegenerative diseases),[2] there is great interest in the synthesis of these natural products in order to develop a deeper understanding of their individual roles.,[1b][3] Resolvins D3 (RvD3, 1) and E1 (RvE1, 2) are typical examples of these polyhydroxylated lipid mediators, with the former being the most potent member of the family.[4]
Figure 1

Pro-resolving natural products: Resolvin D3 (RvD3) (1), resolvin E1 (RvE1) (2), protectin D1 (3), and maresin 1 (4).

Pro-resolving natural products: Resolvin D3 (RvD3) (1), resolvin E1 (RvE1) (2), protectin D1 (3), and maresin 1 (4). Subsequent to their initial discovery and isolation by Serhan et al.,[5] the structures and stereochemistry of RvD3 and RvE1 were confirmed by Petasis and Serhan via total synthesis.[6] Both contain a (Z,E)-diene and a (Z,E,E)-triene motif; in these previous approaches, the isomerization-prone (Z)-alkene of the triene unit was revealed in the final step via semireduction of the corresponding enynes with Zn/Ag/Cu. This tactic has been adopted by others for related resolvins,[7] and has enabled the in vivo testing of the natural products. A further synthesis of resolvin E1 was disclosed in which the (Z)-configured double bonds were introduced from a (Z)-alkenyl bromide via Suzuki coupling, and from a Wittig reaction.[8] Here, we describe an alternative strategy in which late-stage Hiyama–Denmark cross-coupling[9] of cyclic alkenylsiloxanes is used to specifically control the stereochemistry of the (Z)-alkenes in the resolvin polyene motifs.[10] Disconnection at these alkenes (Scheme a) reveals five- and six-membered cyclic alkenylsiloxanes (5/6 and 7/8, respectively), along with two alkenyl iodide resolvin “tails” (9 and 10). RvD3 and RvE1 are ideal candidates for this approach, as in previous work (Scheme b),[10a] we established that five-membered cyclic diethyl alkenylsiloxanes, prepared by Lindlar hydrogenation of the corresponding alkynylsiloxanes, undergo Hiyama coupling more rapidly and under distinct conditions (i.e., KOTMS as activator), compared to six-membered siloxanes (which require fluoride as the coupling promoter). We subsequently found that the more reactive cyclic dimethyl alkenylsiloxanes can be accessed using benzyldimethylsilanes as latent silanols (Scheme c), with the cyclic siloxane revealed through fluoride- or (for five-membered rings) base-mediated debenzylation.[11]
Scheme 1

(a) A Modular Strategy toward Resolvins D3 and E1; (b) Selectivity in the Cross-Coupling of Cyclic Diethylalkenylsiloxanes; (c) Synthesis of Cyclic Dimethylalkenylsiloxanes from Benzyldimethylsilanes

Based on this ring size-dependent reactivity, we planned a “head-to-tail” coupling strategy involving initial selective coupling of five-membered siloxanes 5/6 with dienyl halides 7 or 8, followed by coupling of the residual six-membered siloxane with iodides 9 or 10. Alternatively, we envisaged a “tail-to-head” approach, in which control would be achieved through differentiated rates of oxidative addition (I vs Br) in the initial coupling of iodides 9 or 10 with the central bromodiene siloxane 8. The modular nature of the synthesis would allow access to both the natural products and to novel resolvin analogues by mixing components from the different synthesis streams. As very few unnatural resolvins have been studied, this route could open up opportunities for a wider exploration of the effects of chain length, stereochemistry, and the nature of the head/tail functionality on resolvin biology.[12] The synthesis of the C1–C6 and C1–C7 “head” fragments 5 and 6 (Scheme , required for RvD3 and RvE1, respectively) began with the addition of benzyl(ethynyl)dimethylsilane to the commercially available acid chlorides 11 and 12. The yields of these reactions proved quite dependent on chain length, with 13 formed in 64% yield, but homologue 14 in just 26% yield; fortunately, the latter could be improved to 52% by use of an alkynylzinc.[13] The resulting ketones were converted to the enantioenriched propargylic acetates 15 and 16 through Noyori asymmetric transfer hydrogenation (97%–99% enantiomeric excess (ee)),[14] followed by esterification.[15] Semihydrogenation to the (Z)-benzyldimethyl alkenylsilanes 17 and 18 proceeded with high yield and selectivity (75%–83%, Z:E > 20:1). These products were treated with TBAF, which effected debenzylation, in situ deacetylation, and cyclization to give the cyclic five-membered siloxanes 5 and 6 in excellent yields.
Scheme 2

Synthesis of Resolvin Building Blocks 5–10

Synthesis of the “middle” fragments 7 and 8 (Scheme , common to both RvD3 and RvE1) initially utilized a chiral pool strategy. The addition of lithium benzyldimethylsilylacetylide to TMS-protected (S)-glycidol afforded diol 19 in 98% yield, which was carried through the Lindlar hydrogenation/cyclization sequence[10a] to give the six-membered cyclic alkenylsiloxane 20 (81%). Parikh–Doering oxidation afforded an unstable aldehyde, which was used directly in a Wittig olefination to give enal 21, which displayed greater stability and could be purified by chromatography. Here, a serendipitous discovery was made: residual pyridine from the Parikh–Doering oxidation improved the yield of the olefination from 32% to 52% (43% overall). 21 was converted to dienyl iodide 7 via Takai iodoolefination (60%, E:Z = 5:1). Synthesis of the equivalent bromide 8 was achieved in two steps, consisting of Ramirez olefination (22, 86%), followed by Hirao monodebromination using dimethyl phosphite.[16] This latter reaction is known to exhibit variable selectivity for conjugated systems,[17] and indeed the product bromodiene was obtained as a 2:1 (E,E):(E,Z) mixture. Variation of solvent or temperature did not affect this ratio, and while the bulkier diisopropyl phosphite offered a modest improvement (E:Z = 2.5:1), the conversion decreased significantly. Fortunately, the undesired (E,Z)-dienyl bromide could be removed by elimination of HBr (refluxing NaOMe),[18] followed by Sonogashira coupling of the resulting enyne with 2-iodopyridine. Despite the obstacles encountered, this sequence does illustrate the capacity of the six-membered cyclic dimethylsiloxane to survive a range of reaction conditions. To overcome the limitations of this route, a shorter synthesis was developed, exploiting the Denmark ring-closing metathesis approach to cyclic dimethylsiloxanes.[10b−10f] (E,E)-5-bromopentadienal 23 was readily accessed from SO3·py by alkaline hydrolysis and bromination.[19] The addition of allylmagnesium bromide, followed by Sharpless resolution (98% ee),[20] afforded enantio-enriched alcohol 24. Formation of an intermediate vinyldimethylsilyl ether set the stage for ring-closing metathesis mediated by the Schrock catalyst,[10b−10f] which proceeded in excellent yield (87% over two steps). The resolvin “tail” fragments, destined for coupling with the central six-membered cyclic siloxane, were prepared via base mediated ring-opening of α-iodoepoxides 25 and 26 as developed by Spur[21] and Nakata (Scheme ),[22] which selectively afforded the desired (E)-iodoalkenes 9 and 10 respectively. The configuration of these epoxides was set by Sharpless epoxidation of the corresponding allylic alcohols 27 and 28.[23] With all key fragments in hand, attention turned to assembly of the resolvin framework. We first studied the “head-to-tail” strategy which would rely on an enhanced rate of transmetalation for the five-membered siloxane over the six-membered siloxane in the initial cross-coupling, as had been observed in our earlier work with equivalent diethylsiloxanes (see Scheme , eq 1).[10a] Indeed, we were pleased to find that model fluoride-promoted couplings of iodoalkene 29 with substrates 30 and 31 (Scheme , eq 1) revealed significantly more rapid and higher yielding coupling of the five-membered ring siloxane 30 (91%). However, attempts to translate this reactivity difference to selective coupling of 5 in the presence of the six-membered siloxane in 7 met with failure (Scheme , eq 2), whether using fluoride or KOTMS as the promoter, and with simultaneous or sequential addition of the reactants; side reactions including desilylation, homocoupling, and ester hydrolysis were observed in a variety of model studies. It appeared that while less reactive toward transmetalation, the six-membered ring was nonetheless susceptible to rapid ring opening under the reaction conditions, compromising the ability of the coupling promoter to mediate selective coupling of the five-membered ring.
Scheme 3

Evaluation of Cross-Coupling Strategies

Examination of the “tail-to-head” strategy proved more fruitful. This approach relies on selectivity in the oxidative addition of the resolvin vinyl iodide “tails” (9/10) over the dienyl bromide 8 in the central fragment. We first studied the coupling of RvD3 iodide 9 with 8 (Scheme , eq 3); this coupling proved sluggish and low yielding (30%), and resulted in the formation of a byproduct tentatively assigned as homocoupling of iodide 9.[24] However, reaction of the acetate derivative of the allylic alcohol (35) proceeded at a significantly higher rate, and delivered product 36 in higher yield (63%) and without iodide dimerization. The benefit of acetylation was reinforced in an equivalent model coupling of dienyl iodide 37 with RvE1 “head” siloxane 5 (Scheme , eq 4). Reaction of the free alcohol 37 (to give 39) led to competing formation of a byproduct assigned as an isomerized γ-lactone;[24] use of the acetate 38 derivative suppressed this side reaction and proceeded in higher yield (38 → 40, 55%). We suggest that the free allylic alcohols in 9 or 37 may interfere with the efficiency of coupling by moderating the reactivity of the fluoride activator. Irrespective of the basis of this beneficial effect, the Hiyama–Denmark coupling had now been validated for the formation of both CC bonds, and our attention turned to completion not only of the natural resolvins 1 and 2, but also resolvin hybrids by mixing different natural product building blocks. As such, coupling of 8 and 35 (Scheme ), followed by acetylation, afforded dienyl bromide 41 (53%). This was coupled with siloxanes 5 and 6 to give product alcohols that were immediately acetylated (42 and 43, respectively; 32%–40%)—in part to aid purification from a γ-lactone formed from cyclization of the γ-hydroxyester headgroup,[25] but also to impart stability toward long-term storage of these “pro-resolvins”, compared to the natural products. Resolvin D3 (1)[26] and the RvD3/E1 hybrid 44 were revealed in near quantitative yield upon treatment with lithium hydroxide. Similar coupling of 8 with iodoalkene acetate 45 gave the tetraene 46 after acetylation (58%). Coupling of 46 with the two headgroup siloxanes and acetylation now afforded triacetate pro-RvE1 47 and hybrid 48. Again, these could be saponified in high yield on treatment with aqueous lithium hydroxide to afford resolvin E1 (2)[27] and the RvE1/D3 hybrid 49.
Scheme 4

Synthesis of Resolvins D3, E1, and Hybrids

Reagents and conditions: (a) Pd(dba)2 (5 mol %), TBAF (3 equiv), THF, 16 h; (b) Ac2O, py, CH2Cl2; (c) LiOH, THF/H2O (1:1).

Synthesis of Resolvins D3, E1, and Hybrids

Reagents and conditions: (a) Pd(dba)2 (5 mol %), TBAF (3 equiv), THF, 16 h; (b) Ac2O, py, CH2Cl2; (c) LiOH, THF/H2O (1:1). In conclusion, resolvins D3 and E1 were prepared in 12 steps in the longest linear sequence (∼20 steps total), employing Hiyama cross-coupling of cyclic alkenylsiloxanes in key fragment union transformations. The modular and convergent nature of the route also enabled the synthesis of new resolvin analogues. These enantioselective syntheses open up opportunities for a wider study of the role of these (Z)-alkenyl polyene natural products in inflammatory response pathways; studies to this end are ongoing in our group.
  30 in total

1.  Concise and highly stereoselective synthesis of the C20-C26 building block of halichondrins and Eribulin.

Authors:  Mingde Shan; Yoshito Kishi
Journal:  Org Lett       Date:  2012-01-11       Impact factor: 6.005

Review 2.  Silicon-based cross-coupling reactions in the total synthesis of natural products.

Authors:  Scott E Denmark; Jack H-C Liu
Journal:  Angew Chem Int Ed Engl       Date:  2010-04-12       Impact factor: 15.336

3.  Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.

Authors:  Sungwhan F Oh; Padmini S Pillai; Antonio Recchiuti; Rong Yang; Charles N Serhan
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

4.  Sequential ring-closing metathesis and silicon-assisted cross-coupling reactions: stereocontrolled synthesis of highly substituted unsaturated alcohols.

Authors:  S E Denmark; S M Yang
Journal:  Org Lett       Date:  2001-05-31       Impact factor: 6.005

Review 5.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

6.  Intramolecular silicon-assisted cross-coupling reactions: general synthesis of medium-sized rings containing a 1,3-cis-cis diene unit.

Authors:  Scott E Denmark; Shyh-Ming Yang
Journal:  J Am Chem Soc       Date:  2002-03-13       Impact factor: 15.419

7.  Stereocontrolled synthesis of resolvin D1.

Authors:  Masao Morita; Shangze Wu; Yuichi Kobayashi
Journal:  Org Biomol Chem       Date:  2019-02-20       Impact factor: 3.876

8.  Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance.

Authors:  Jeremy W Winkler; Sarah K Orr; Jesmond Dalli; Chien-Yee C Cheng; Julia M Sanger; Nan Chiang; Nicos A Petasis; Charles N Serhan
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

9.  Ruthenium-catalyzed vinylsilane synthesis and cross-coupling as a selective approach to alkenes: benzyldimethylsilyl as a robust vinylmetal functionality.

Authors:  Barry M Trost; Michelle R Machacek; Zachary T Ball
Journal:  Org Lett       Date:  2003-05-29       Impact factor: 6.005

Review 10.  Proresolving lipid mediators and mechanisms in the resolution of acute inflammation.

Authors:  Christopher D Buckley; Derek W Gilroy; Charles N Serhan
Journal:  Immunity       Date:  2014-03-20       Impact factor: 31.745

View more
  4 in total

1.  Synthesis of Resolvin E1 and Its Conformationally Restricted Cyclopropane Congeners with Potent Anti-Inflammatory Effect.

Authors:  Kohei Ishimura; Hayato Fukuda; Koichi Fujiwara; Ryuta Muromoto; Koki Hirashima; Yuto Murakami; Mizuki Watanabe; Jun Ishihara; Tadashi Matsuda; Satoshi Shuto
Journal:  ACS Med Chem Lett       Date:  2021-01-21       Impact factor: 4.345

2.  Stereoselective Synthesis and Structural Confirmation of the Specialized Pro-Resolving Mediator Resolvin E4.

Authors:  Amalie Føreid Reinertsen; Karoline Gangestad Primdahl; Ashley Elizabeth Shay; Charles Nicholas Serhan; Trond Vidar Hansen; Marius Aursnes
Journal:  J Org Chem       Date:  2021-02-03       Impact factor: 4.354

Review 3.  Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation.

Authors:  Inês Ferreira; Filipa Falcato; Narcisa Bandarra; Amélia P Rauter
Journal:  Molecules       Date:  2022-03-03       Impact factor: 4.411

4.  Stereoselective Synthesis, Configurational Assignment and Biological Evaluations of the Lipid Mediator RvD2n-3 DPA.

Authors:  Amalie F Reinertsen; Karoline G Primdahl; Roberta De Matteis; Jesmond Dalli; Trond V Hansen
Journal:  Chemistry       Date:  2021-12-28       Impact factor: 5.020

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.